Global Glycyrrhetinic Acid (CAS 471-53-4) Market Study 2016-2026, by Segment (HPLC < 95%, HPLC 95%-98%, … …), by Market (Pharmaceutical, Cosmetic, … …), by Company (Fujie Pharmaceutical, QHL Pharma, … …)
Glycyrrhetinic Acid (also known as Enoxolone or glycyrrhetic acid) is a pentacyclic triterpenoid derivative of the beta-amyrin type obtained from the hydrolysis of glycyrrhizic acid, which was obtained from the herb liquorice. It is used in flavoring and it masks the bitter taste of drugs like aloe and quinine. It is effective in the treatment of peptic ulcer and also has expectorant (antitussive) properties. It has some additional Electronics & Softwarermacological properties including antiviral, antifungal, antiprotozoal, and antibacterial activities.
The global Glycyrrhetinic Acid (CAS 471-53-4) market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
HPLC < 95%
HPLC > 98%
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Company Coverage (Sales data, Main Products & Services etc.):
Selco Wirkstoffe Vertriebs GmbH
Jiangsu Tiansheng Pharmaceutical
Middle East & Africa
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.